Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
This bill amends 21 U.S.C. 823 (Section 303 of the Controlled Substances Act) to clarify and expand the list of recognized professional organizations, accrediting bodies, and educational programs referenced in the statute on required training for prescribers of controlled substances. It redesignates a subsection, inserts additional professions and organizations (for example, family physicians, podiatric and dental bodies, optometry, pharmacy organizations, and nursing associations), and makes the amendments effective retroactively to December 29, 2022.
Liberal emphasizes safety and inclusive professional recognition
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that precisely edits 21 U.S.C. 823 to expand and clarify which accrediting organizations and curricular language satisfy training requirements for prescribers of controlled substances, and it sets a retroactive effective date.
This bill amends 21 U.S.C. 823 (Section 303 of the Controlled Substances Act) to clarify and expand the list of recognized professional organizations, accrediting bodies, and educational programs referenced in the statute on required training for prescribers of controlled substances.
It redesignates a subsection, inserts additional professions and organizations (for example, family physicians, podiatric and dental bodies, optometry, pharmacy organizations, and nursing associations), and makes the amendments effective retroactively to December 29, 2022.
Technical, noncontroversial statutory clarification with minimal fiscal impact historically fares well, though calendar and stakeholder priorities matter.
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that precisely edits 21 U.S.C. 823 to expand and clarify which accrediting organizations and curricular language satisfy training requirements for prescribers of controlled substances, and it sets a retroactive effective date.
Liberal emphasizes safety and inclusive professional recognition
These are examples from the analysis, not a ranked list of the most-affected groups.
Liberal emphasizes safety and inclusive professional recognition
Likely supportive because the bill expands recognized training pathways and includes more health professions, which can improve standardized training and patient safety.
May see it as an incremental, professionalized approach to controlled substance prescribing oversight.
Generally favorable as a technical, targeted clarification improving statutory specificity and patient safety.
Wants assurances about implementation, cost, and minimal disruption to current practice.
Skeptical about expanding federal statutory detail on training and additional recognized bodies; concerned about increased federal involvement and potential limits on prescriber autonomy.
May accept modest clarifications but worries about regulatory creep.
Reached or meaningfully advanced
Reached or meaningfully advanced
Still ahead
Still ahead
Still ahead
Technical, noncontroversial statutory clarification with minimal fiscal impact historically fares well, though calendar and stakeholder priorities matter.
The bill has not accumulated any surfaced votes yet.
Liberal emphasizes safety and inclusive professional recognition
Technical, noncontroversial statutory clarification with minimal fiscal impact historically fares well, though calendar and stakeholder pri…
Relative to its intended legislative type, this bill is a narrowly focused statutory amendment that precisely edits 21 U.S.C. 823 to expand and clarify which accrediting organizations and curricular language satisfy tra…
Go beyond the headline summary with full stakeholder mapping, legislative design analysis, passage barriers, and lens-by-lens tradeoff breakdowns.